low voltage mixed frequency EEG pattern with bursts of rapid conjugate eye movements (REMs) and profound abolition of tone in the neck muscles. The phenomena in the REM state can be classified into the following two groups: tonic (continuous physiological changes) and phasic (periodic changes). The main tonic events, which persist continuously through the REM state, are the low voltage mixed frequency EEG pattern similar to that accompanying arousal, hippocampal theta rhythm and the abolition of nuchal muscle tone. The phasic phenomena include bursts of rapid eye movements and, in the cat, high voltage spikes, isolated or grouped in volleys that appear in the pons, lateral geniculate nucleus and occipital cortex. These are known as ponto-geniculo-occipital (PGO) spikes. They make their appearance about 0-5-1 min before the occurrence of the tonic phenomenon and subsequently accompany the bursts of REM. The PGO spikes come at a remarkably constant rate; about 60-70 min, or 1400/day (Jouvet, 1967) . The organism is in a state of intense physiological activity during the REM state. Cerebral blood flow is greater than that during wakefulness. Heart rate, respiration and blood pressure become highly variable with higher mean levels. The penis is in a state of tumescence.
When awakened from REM sleep the subject is likely to report vivid dreams with much visual imagery. This contrasts with the mentation reported on waking from NREM sleep, which tends to consist of specific thoughts, devoid of dramatic story content, with minimal sensory imagery, those images that are present being vague, static or fragmentary (Freemon, 1972; Rechtschaffen, 1973) . Both REM and NREM mentation slip rapidly from the memory unless rehearsed immediately on reawakening. Hence, a subject may deny having any dreams or interruption with his previous night's sleep, only to find to his surprise that he not only had vivid REM mentation but was awakened and gave a detailed dream report (Baekeland and Lasky, 1968 (Verdone, 1965 Webb, 1964, 1966; Agnew and Webb, 1968a; Kales et al., 1967a, b, c (Kales et al., 1967; Feinberg, Koresko and Heller, 1967; Feinberg, 1974 (Oswald, 1973 (Takahaski, Kipnis and Daughaday, 1968; Parker et al., 1969) . This physiologically maximal HGH release in slow wave sleep has been taken as evidence that slow wave sleep has an anabolic protein sparing restorative function . (Weitzman, 1972) .
Regarding the pituitary gonadotrophins, Rubin (1972) Nankin and Troen (1972) have observed that the pituitary release of LH occurs as repetitive abrupt discharges in healthy adult men during the night with highest levels in the early morning. Kapen (1972) has studied several females at various phases of the menstrual cycle. During menstruation, the episodic release of LH is infrequent, with low amplitude peaks. Just before ovulation the episodic release of LH is more prominent, with high amplitude peaks of secretion occurring, half of which occur in REM periods. The secretory episodes also seem to be more frequent with high amplitude peaks in the latter part of the follicular phase. Finkelstein et al. (1973) have reported, that plasma LH output is synchronized with sleep at the beginning of puberty with the secretion during sleep being greatly augmented during puberty. These workers observed that, when sexual maturation is complete, the rise in LH secretion during sleep is lost. A more recent study from the same laboratory has sampled plasma LH and testosterone levels at 20-min intervals for 24 hr in nine pubertal boys and three sexually mature young men (Boyar et cl., 1974) . In all nine pubertal boys the plasma testosterone concentration fluctuated and was significantly higher during normal nocturnal sleep as compared to daytime waking. This increased testosterone during sleep was temporally linked to the pubertal sleep augmentation of LH secretion. Reversal of sleep in three of the boys showed that the plasma testosterone concentrations were now augmented during the reversed daytime sleep period. Measurement of the plasma LH and testosterone levels in the three sexually mature young men showed episodic secretion peaks of LH and testosterone both during waking and sleep periods. There was no consistent increase of LH or testosterone secretion during sleep in the young adult males, nor was there any relationship between plasma LH and testosterone levels, neither during sleep nor wakefulness. Other all-night studies of adult males have reported a decline in plasma testosterone levels with sleep onset, with a subsequent increase in the latter part of the night, reaching a peak in the early morning between 6 and 7 a.m., with many fluctuations, which tend to occur at or before onset of REM periods (Evans et al., 1971; Rowe et al., 1974) . Ban (1972) has reported a diurnal fluctuation in triiodothyronine 131I resin sponge uptake (T3RSU) with its peak during sleep. On the other hand plasma thyroxine concentrations sampled at 20-min intervals throughout the 24 hr have revealed slightly higher levels during wakefulness than during sleep (O'Connor et al., 1974) . Disturbance in thyroid function certainly affects slow wave sleep, a marked reduction occurring in hypothyroidism (Kales et al., 1967) and an increased percentage in hyperthyroidism (Dunleavy et al., 1974) . The parathyroid hormone shows a maximum output between the hours of 2 and 4 a.m. (Jubiz et al., 1972) .
Neural mechanisms of sleep
The neural mechanisms of sleep and waking are complex and still the subject of much debate. The present position has been elegantly reviewed by Moruzzi (1972) . The ascending reticular system and a group of neurones lying in the posterior hypothalamus appear to be endowed with a tonic activating influence and are concerned with the maintenance of wakefulness. In contrast, the lower brainstem (middle and upper middle pons in the region of the solitary tract) and basal forebrain (preoptic region of the anterior hypothalamus) contain structures with an opposing function. These actively inhibit the more rostral portions of the mid-brain reticular formation with consequent synchronization of cortical rhythms and the induction of sleep accompanied by NREM EEG patterns.
The trigger for REM sleep has been located in the pons by a series of coagulation studies in which complete destruction of the nucleus reticularis pontis caudalis has been shown to eliminate REM sleep without affecting NREM sleep. The ascending route from this centre to the cortex has not yet been defined. Bilateral destruction of the locus coeruleus, a pontine nucleus rich in noradrenaline, abolishes the tonic atonia of the REM state due to interference with the descending inhibitory system, which via the reticulo spinal pathways inhibits the spinal anterior horn cells (Jouvet, 1972) . The neural basis of the phasic REM components appears to be separate, involving the lateral vestibular nuclei and ocular motor control centres (Pompeiano and Morrison, 1965) .
Neurotransmitters and sleep Jouvet (1972) has reviewed the role of monoamines and acetylcholine containing neurones in the regulation of sleep. He hypothesizes that the 5-hydroxytryptamine (5-HT)-rich neurones in the anterior raphe system* are responsible for behavioural and slow wave sleep. The 5-HT neurones in the caudal raphe nuclei prime REM sleep mechanisms by sending terminals to the caudal two thirds of the locus coeruleus. This in turn is responsible for total inhibition of muscle tone associated with REM. On the other hand the medial third of the locus coeruleus (pontine pace maker) is responsible for both the phasic and tonic ascending REM components. The 5-HT priming mechanisms may trigger the locus coeruleus thus causing the onset of REM while terminals from the locus coeruleus in turn suppress re-uptake of 5-HT thus allowing the REM state to develop. Acetylcholine and noradrenaline are concerned with the maintenance of REM while PGO activity appears to be inhibited by 5-HT. Alterations between slow wave sleep and REM sleep are produced by alternating 5-HT release (SWS) and re-uptake (REM). The anterior noradrenaline-containing cells of the locus coeruleus in the pons cause waking. According to Jouvet, the neurotransmitter involved with the maintenance of wakefulness is acetylcholine.
However, the biochemical findings in recent human sleep studies (Wyatt, 1972) Thus the hypothesis that 5-HT is primarily involved in initiating and sustaining NREM sleep is not supported by human sleep studies.
In fact, the available evidence points to 5-HT metabolites having a role in triggering the REM * The raphe system is a collection of midline nuclei situated in the brain stem, clustered in nine groups from the nucleus raphe obscurus in the medulla to the nucleus linearis in the mesencephalon. As hypothesized by Jouvet, the adrenergic system may also play a role in REM control. ac-Methylparatyrosine (AMPT) and oc-methyl-phenyl-alanine (AMPA) are both tyrosine hydroxylase inhibitors and decrease the content of brain catecholamines. Both were found to increase REM sleep time, while L-dopa, a catecholamine precursor, decreased REM sleep. Thus, in man, it appears that high brain catecholamine concentrations decrease REM, while lowering catecholamine levels augments REM. Wyatt (1972) claims that these findings indicate that the REM state is controlled by an interaction between the serotonergic and adrenergic systems, with 5-HT augmenting and catecholamines reducing the REM state. There is considerable biochemical evidence that catecholamines can modify 5-HT metabolism.
Humoral factors
Humoral factors may play a role in the genesis of sleep. Recipient rabbits infused with a dialysate from the cerebral sinuses of sleeping donor rabbits (sleep being induced by stimulation of the ventromedial intralaminar thalamic nuclei) developed SWS (Monnier and Hatt, 1971; Monnier et al., 1972) . Fencl, Koki and Pappenheimer (1971) have also isolated a factor derived from sleep-deprived goat C.S.F. which increases sleep time and decreases locomotor activity in rats.
